A previous study showed that RACGAP1 regulated the downstream factors of the PI3K/AKT signaling pathway and that the compensatory activation of the PI3K/AKT signaling pathway was closely associated with ADT drug resistance and neuroendocrine differentiation in PCa [13]. This evidence concerns the gene RACGAP1 and posterior cortical atrophy.